Sutent price (correction)
Based on the wholesale acquisition cost of Sutent (sunitinib), which is $6,412.50 for a 30 count bottle of 50 mg capsules, the product's average monthly cost is $4,275. This prices Sutent at a slight discount to Bayer/Onyx' Nexavar (sorafenib) which carries a WAC of $4,333 for a one-month supply. In a previous story on the approval of Sutent, "The Pink Sheet" incorrectly identified the price of the product and incorrectly referred to the average wholesale price of Nexavar as the price to patients (1"The Pink Sheet" Jan. 30, 2006, p. 4)...
You may also be interested in...
Pfizer's newly approved oncologic Sutent will have a dosing advantage and will be priced at a slight discount compared to Bayer/Onyx' Nexavar
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
Other antibody treatments have shown efficacy in early-stage disease after faltering in hospitalized patients.